Prostate cancer is one of the most common cancers diagnosed among men worldwide. Castrate resistant prostate cancer (CRPC) refers to prostate cancer that continues to progress even after androgen deprivation therapy through surgical or chemical castration. Products like chemotherapy drugs, hormone therapy drugs, immunotherapy, and radiation therapy are used for treating CRPC. The increasing...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian